WASHINGTON — The U.S. Food and Drug Administration announced they will eliminate the safety requirement of in-person dispensing in the Risk Evaluation Mitigation Strategy for the chemical abortion drug mifepristone. The FDA’s action clears a ...
Get our WNYCatholic newsletter in your inbox today!
All the latest local, national and world Catholic news, messages from our Bishop, stunning photography and inspiring feature stories — twice each week via email.
Email (required) *
First Name *
Example: Yes, I would like to receive emails from Western New York Catholic. (You can unsubscribe anytime)